Abstract

Simple SummaryIt is recognized that the current developmental neurotoxicity (DNT) testing paradigm is not fit-for -purpose for the assessment of a large number of chemicals. In the last two decades there have been scientific advances made for evaluating chemical interactions with the developing nervous system that rely on alternative to animal methods. The Organisation for Economic Co-Operation and Development (OECD) provides a forum to develop internationally harmonised guidance to test and assess chemicals for DNT that is primarily based on cellular models. Given the complexity of the developing nervous system and the availability of a number of non-animal methods to address DNT, integration of data from multiple studies is necessary and an OECD framework for organising existing scientific knowledge can be applied as the canvas of this integration. Herein, we provide a brief overview of the OECD DNT project and summarize various achievements of relevance to the project. The review also presents an opportunity to describe considerations for uptake of the DNT non animal methods in a regulatory context.Characterization of potential chemical-induced developmental neurotoxicity (DNT) hazard is considered for risk assessment purposes by many regulatory sectors. However, due to test complexity, difficulty in interpreting results and need of substantial resources, the use of the in vivo DNT test guidelines has been limited and animal data on DNT are scarce. To address challenging endpoints such as DNT, the Organisation for Economic Co-Operation and Development (OECD) chemical safety program has been working lately toward the development of integrated approaches for testing and assessment (IATA) that rely on a combination of multiple layers of data (e.g., in vitro, in silico and non-mammalian in vivo models) that are supported by mechanistic knowledge organized according to the adverse outcome pathway (AOP) framework. In 2017, the OECD convened a dedicated OECD expert group to develop a guidance document on the application and interpretation of data derived from a DNT testing battery that relies on key neurodevelopmental processes and is complemented by zebrafish assays. This review will provide a brief overview of the OECD DNT project and summarize various achievements of relevance to the project. The review also presents an opportunity to describe considerations for uptake of the DNT in an in vitro battery in a regulatory context.

Highlights

  • It is well documented that certain chemicals can adversely interact with the development of the nervous system in humans [1]

  • Recognition of the importance of safeguarding the developing nervous system from chemical exposure is evident through the acknowledgment that characterization of developmental neurotoxicity (DNT) hazard potential for chemicals is considered for risk assessment by various regulatory sectors and is embedded in many regional legislations

  • The adverse outcome pathway (AOP) conceptual framework describes a sequence of measurable key events (KEs) which are expected to be triggered by the activation of a molecular initiating event, MIE

Read more

Summary

Introduction

It is well documented that certain chemicals can adversely interact with the development of the nervous system in humans [1]. No standard regulatory data requirements for DNT currently exist in any of the chemical regulatory sectors; most commonly, an observational finding related to neurotoxicity detected in other routinely conducted in vivo studies might trigger in vivo DNT testing [12]. This fact, accompanied by substantial resource requirements, test complexity, difficulty in interpreting data and ethical reservations, limits the use of the in vivo DNT test guidelines. This review paper provides an overview of an international effort to develop guidance on in vitro assays for use in a DNT testing battery under the auspices of the OECD. The review presents considerations for uptake of the guidance that could facilitate countries and industry to enhance DNT testing of chemicals, focusing on the incorporation of mechanistic understanding and practical examples that are applicable in a regulatory context

Overview of the OECD DNT Project
Assays of the Proposed Battery
Processes behind Selection of the Chemicals for Testing
Availability of In Vitro DNT Data
Usefulness of the Battery
Case Studies
Adverse Outcome Pathways
Regulatory Engagement
Conclusions
Disclaimers
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call